Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Antibiotic prescribing patterns in four surgical diagnoses groups at surgery departments of the TH and NTH

From: Perioperative antibiotic prescribing in surgery departments of two private sector hospitals in Madhya Pradesh, India

 

UUTSI

LUTSI

RASI

EASI

TH, N = 563

NTH, N = 1055

TH, N = 1624

NTH, N = 1453

TH, N = 2767

NTH, N = 1240

TH, N = 1435

NTH, N = 1679

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Tetracyclines (J01A), n (% of N)

32 (6)

2 (< 1)

50 (3)

0

233 (8)

6 (< 1)

98 (7)

2 (< 1)

Amphenicols (J01B), n (% of N)

0

0

0

0

0

0

1

0

Penicillins (J01C), n (% of N)

17 (3)

42 (4)

77 (5)

80 (6)

219 (8)

80 (6)

131 (9)

147 (9)

 Penicillins with extended spectrum (J01CA), x (% of n)

3 (18)

2 (5)

5 (6)

4 (5)

21 (10)

16 (20)

0

10 (7)

 Penicillins combinations including enzyme inhibitors (J01CR), x (% of n)

14 (82)

40 (95)

72 (94)

76 (95)

198 (90)

64 (80)

131 (100)

137 (93)

Other beta-lactam antibiotics (J01D), n (% of N)

70 (12)

239 (23)

220 (14)

191 (13)

535 (19)

332 (27)

218 (15)

296 (18)

 First-generation cephalosporins J01DB, x (% of n)

19 (27)

7 (3)

49 (22)

1 (< 1)

149 (28)

17 (5)

50 (23)

11 (4)

 Second-generation cephalosporins J01 DC, x (% of n)

0

9 (4)

13 (6)

24 (13)

23 (4)

41 (12)

5 (2)

29 (10)

 Third-generation cephalosporins J01DD, x (% of n)

51 (72)

222 (93)

158 (72)

166 (87)

363 (68)

272 (82)

162 (74)

254 (86)

 Fourth-generation cephalosporins J01DE, x (% of n)

0

1 (< 1)

0

0

0

1 (< 1)

0

0

 Carbapenems J01DH, x (% of n)

0

0

0

0

0

1 (< 1)

1 (< 1)

2 (< 1)

Sulfonamids and trimethoprim (J01E), n (% of N)

11 (2)

0

85 (5)

0

100 (4)

0

16 (1)

0

Macrolids and lincosamids (J01F), n (% of N)

38 (7)

0

180 (11)

2 (< 1)

405 (15)

3 (< 1)

94 (7)

8 (< 1)

 Macrolids (J01FA), x (% of n)

0

0

4 (2)

0

3 (< 1)

0

1 (1)

0

 Lincosamids (J01FF), x (% of n)

38 (100)

0

176 (98)

2 (100)

402 (99)

3

93 (99)

8 (100)

Aminoglycosides (J01G), n (% of N)

76 (13)

269 (26)

328 (20)

449 (31)

486 (18)

250 (20)

189 (13)

225(13)

Quinolones (J01 M), n (% of N)

216 (38)

281 (27)

609 (38)

543 (37)

315 (11)

114 (9)

263 (18)

145 (9)

Fixed-dose combinations (J01R), n (% of N)

3 (1)

160 (15)

22 (1)

155 (11)

37 (1)

298 (24)

17 (1)

399 (24)

 Quinolones and imidazole derivatives*, x (% of n)

0

2 (1)

0

17 (11)

0

26 (9)

0

22 (6)

 Cephalosporins and enzyme inhibitors, x (% of n)

3 (100)

158 (99)

22 (100)

138 (89)

37

272 (91)

17 (100)

377 (94)

Other antibiotics (J01X), n (% of N)

100 (18)

62 (6)

53 (3)

33 (2)

437 (16)

157 (13)

408 (28)

457 (27)

 Imidazole derivatives (J01XD)**, x (% of n)

100 (100)

62 (97)

53 (100)

31 (94)

437 (100)

157 (100)

408 (100)

453 (99)

 Other antibiotics (J01XX), x (% of n)

0

2 (3)

0

2 (6)

0

0

0

4 (1)

  1. EASI emergency abdominal surgery indications, LUTSI lower urinary tract surgery indications, N total number of prescriptions in the diagnosis group, n number of prescriptions for the third-level ATC pharmacological sub-group, RASI routine abdominal surgery indications, UUTSI upper urinary tract surgery indications, x number of prescriptions for the fourth-level ATC pharmacological sub-group. Percentages were rounded and presented in parenthesis
  2. *Fixed-dose combinations that were not assigned by WHOCC, a fourth level ATC-code
  3. **The imidazole derivate group also included oral metronidazole categorized as P01AB01